Moderna Reports mNEXSPIKE Real-World Vaccine Effectiveness Data

A study of more than 294,000 U.S. veterans aged 65 and older found mNEXSPIKE was associated with a 35.9% lower risk of medically attended COVID-19 and a 47% lower risk of COVID-19-associated hospitalization versus Comirnaty.